|
Market Cap (25-Jun) $125,067,280 (1,258th) |
Close (30-Jun) $0.007 |
Volume (30-Jun) 188,484 |
Shortsold (14-May) 14,985,846 (0.14%) (426th) |
|
52w High $0.85 |
52w Low $0.350 |
P/E 10.33 |
EPS -0.07 |
ATH released this announcement to the ASX on 26 May 2022, 12:35. The announcement is not marked as price sensitive, and is 1 page(s) in length and 156.3kb in size.
You can view all announcements from ATH and see how they appear on a price chart on the announcements page.
At the date of this announcement, ATH was 0.001% short sold according to ASIC data. It was ranked the 636th most shorted stock on the ASX. It is now ranked as the 426th most shorted stock on the ASX with 0.138% of total shares short sold as of the latest reported data (14 May 2026).
| Other Recent Announcements from ATH | |
|---|---|
| Investor Presentation | 22 June 2023, 11:13 |
| ATH to present at MST Rare Diseases Rich Returns Forum | 21 June 2023, 9:52 |
| ATH starts 2nd Phase 2 Study in Rare Parkinsonian Disorder | 30 May 2023, 13:32 |
| Alterity to Participate in the Benchmark Company Conference | 26 May 2022, 12:35 |
| Change in substantial holding | 4 May 2022, 8:10 |
| Appendix 4C and Quarterly Cash Flow Report | 29 April 2022, 14:07 |
| UK Regulatory Authorisation to Proceed with Phase 2 Trial | 27 April 2022, 12:06 |
You must be logged in to post a reply.
Alterity Therapeutics 